Keppra Tablet, Film Coated
RxNorm Crosswalk NDC 50474-596

View RxNorm Concepts, RxCUIs, and Term Type mappings for this NDC

RxNorm Mapping Clinical Concepts

This drug is included in the RxNorm Current Prescribable Content, a subset of RxNorm that includes all drugs available for prescription in the United States.

The product Keppra (NDC 50474-596) is cross-mapped to the RxNorm terminology system to ensure clinical interoperability. This product is associated with 10 unique RxNorm concepts. By anchoring Ucb, Inc.'s product data to these standardized identifiers, healthcare systems can maintain accurate medication records, safely automate e-prescribing, and streamline pharmacy workflows.

The following clinical concept cards detail the semantic term types (TTY), prescribable names, and synonymous clinical strings as defined by the National Library of Medicine (NLM).

PSNPrescribable
Featured Concept

Keppra 250 MG Oral Tablet
(RxCUI 261335)

Prescribable Name

Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.

PSNPrescribable
Featured Concept

Keppra 500 MG Oral Tablet
(RxCUI 261336)

Prescribable Name

Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.

PSNPrescribable
Featured Concept

Keppra 750 MG Oral Tablet
(RxCUI 284391)

Prescribable Name

Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.

SCDPrescribable
Featured Concept

levetiracetam 250 MG Oral Tablet
(RxCUI 311288)

Semantic Clinical Drug

Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.

SCDPrescribable
Featured Concept

levetiracetam 500 MG Oral Tablet
(RxCUI 311289)

Semantic Clinical Drug

Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.

SCDPrescribable
Featured Concept

levetiracetam 750 MG Oral Tablet
(RxCUI 311290)

Semantic Clinical Drug

Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.

SCDPrescribable
Featured Concept

levetiracetam 1000 MG Oral Tablet
(RxCUI 387003)

Semantic Clinical Drug

Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.

SCDPrescribable
Featured Concept

levetiracetam 100 MG/ML Oral Solution
(RxCUI 403884)

Semantic Clinical Drug

Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.

PSNPrescribable
Featured Concept

Keppra 100 MG in 1 mL Oral Solution
(RxCUI 404595)

Prescribable Name

Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.

PSNPrescribable
Featured Concept

Keppra 1000 MG Oral Tablet
(RxCUI 630807)

Prescribable Name

Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.

Understanding RxNorm Mapping for Keppra

RxNorm is a normalized naming system developed by the National Library of Medicine (NLM) to bridge the gap between different drug terminologies. By mapping NDC 50474-596 to RxCUI 261335, 261336, 284391, 311288, 311289, 311290, 387003, 403884, 404595, 630807, this page provides the standardized "source of truth" required for hospital systems, e-prescribing software, and pharmacy benefit managers (PBMs) to communicate without errors.

Term Type (TTY) Legend for This Page

The clinical cards above utilize specific Term Types (TTY) to define the granularity of the drug concept:

  • PSN Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.
  • SBD Semantic Branded Drug: The branded equivalent representing the Brand Name + Strength + Dosage Form.
  • SY Synonym: An alternative clinical name or alias provided for search and retrieval clarity.
  • SCD Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.

* Please review the full disclaimer at the bottom of this page.